Free Trial
→ Your $29.97 book is free today (From Profits Run) (Ad)tc pixel
NASDAQ:PRE

Prenetics Global 6/18/2024 Earnings Report

Prenetics Global logo
$16.16 +0.29 (+1.83%)
Closing price 05/8/2026 04:00 PM Eastern
Extended Trading
$15.74 -0.42 (-2.61%)
As of 05/8/2026 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
ProfileEarnings HistoryForecast

Prenetics Global EPS Results

Actual EPS
-$0.38
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Prenetics Global Revenue Results

Actual Revenue
$6.41 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Prenetics Global Announcement Details

Quarter
Date
6/18/2024
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Prenetics Global's Q1 2026 earnings is estimated for Thursday, May 14, 2026, based on past reporting schedules, with a conference call scheduled at 8:00 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Q1 2026 Earnings Report

Conference Call Resources

Prenetics Global Earnings Headlines

Prenetics Global Limited to Announce Q1 2026 Financial Results on May 14, 2026
May 8 at 8:50 AM  |  quiverquant.comQ
Prenetics to Report Q1 2026 Financial Results on May 14, 2026 and Host Earnings Conference Call
May 8 at 8:30 AM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/05/08/3291051/0/en/prenetics-to-report-q1-2026-financial-results-on-may-14-2026-and-host-earnings-conference-call.html
I was right about SpaceX
Jeff Brown predicted Bitcoin before it climbed as high as 52,400%, Tesla before 2,150%, and Nvidia before 32,000%. Now he says SpaceX is shaping up to be the biggest IPO of the decade - and three key milestones just confirmed it. In the past 21 days: SpaceX crossed 10,000 active satellites, Elon filed confidential IPO paperwork with the SEC, and another rocket launched 25 more satellites. Two-thirds of every satellite in orbit now belongs to one company. The public filing could drop any day.tc pixel
May 9 at 1:00 AM  |  Brownstone Research (Ad)
Prenetics’ IM8 Named Exclusive Health Supplements Partner of Inter Miami CF in Multi-Year Partnership
May 7 at 1:56 PM  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/prenetics-im8-named-exclusive-health-supplements-partner-of-inter-miami-cf-in-multi-year-partnership-1036120172
Prenetics' IM8 Named Exclusive Health Supplements Partner of Inter Miami CF in Multi-Year Partnership
May 7 at 8:30 AM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/05/07/3290010/0/en/prenetics-im8-named-exclusive-health-supplements-partner-of-inter-miami-cf-in-multi-year-partnership.html
Prenetics to Exit Bitcoin Holdings and Reinvest Up to $40 Million in Core IM8 Health Business
May 6 at 5:52 PM  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/PRE/pressreleases/1711970/prenetics-to-exit-bitcoin-holdings-and-reinvest-up-to-40-million-in-core-im8-health-business/
See More Prenetics Global Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Prenetics Global? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Prenetics Global and other key companies, straight to your email.

About Prenetics Global

Prenetics Global (NASDAQ:PRE) (NASDAQ: PRE) is a molecular diagnostics and genetic testing company that delivers a broad range of laboratory and at-home testing solutions. The company’s core offerings include next-generation sequencing (NGS) panels for hereditary health risks, pharmacogenomic reports to guide medication choices, and comprehensive consumer DNA testing services. In addition to genetic insights, Prenetics provides infectious disease diagnostics—most notably real-time PCR testing for pathogens such as SARS-CoV-2—through an integrated platform that combines sample collection, laboratory processing and digital reporting.

Serving both business-to-consumer and business-to-business markets, Prenetics operates a network of laboratories and service centers across Asia Pacific, Europe, the Middle East and North America. Its consumer brand, CircleDNA, offers a direct-to-consumer genetic testing kit that reports on wellness traits, nutrition, fitness and inherited disease risks. On the corporate side, the company partners with healthcare providers, sports organizations and governments to deploy large-scale testing programs and personalized health initiatives. Prenetics also supports telehealth services, enabling remote consultations based on genetic and diagnostic results.

Founded in 2014 and headquartered in Hong Kong, Prenetics was established by CEO Danny Yeung, a tech entrepreneur with a background in fintech and digital platforms. Under his leadership, the company has expanded through strategic partnerships and investments in laboratory automation and data analytics. Prenetics completed a public listing on the Nasdaq in 2022, positioning itself to accelerate global market expansion and further develop its precision health offerings.

View Prenetics Global Profile
Earnings Tools